Research Figures
Data from the Scientific Report 2022
- 525 Projects
- 406 Clinical Trials
- 816 Publications
- 5563 Total Impact Factor
News
A study led by SJD identifies new therapeutic targets for Ewing sarcoma
The study identifies the demethylases KDM6A and KDM6B as essential collaborators of the fusion protein EWSR1::FLI1, responsible for the epigenetic reprogramming that drives tumor growth.
A study by Sant Joan de Déu identifies the mechanisms that hinder the effectiveness of treatment for diffuse intrinsic pontine glioma in children
DIPG is an aggressive brain tumor that mainly affects pediatric patients and has a poor prognosis in all cases. The research team has identified two key proteins secreted by the tumor that suppress the immune system and promote the formation of barriers that hinder treatment.
Interviews
Susana Ochoa Güerre
Psychologist, head of the Research Group on Etiopathogenesis and Treatment of Severe Mental Disorders (MERITT) at the Institut de Recerca Sant Joan de Déu (IRSJD) and head of research at the Parc Sanitari Sant Joan de Déu (PSSJD).
Agenda
Defensa tesi doctoral: Carmen Corral Partearroyo
"Improving initial medication adherence in primary care: pragmatic evaluation of a complex behavioural intervention"
#ViernesCientíficos |Desafíos de los servicios de salud y respuestas desde el conocimiento en cuidados
Seminario con cargo al Dr. José Miguel Morales Asencio. Enfermero. Catedrático de Universidad. Vicedecano de Postgrado, Investigación y Transferencia. Coordinador del Programa de Doctorado en Ciencias de la Salud. Facultad de Ciencias de la Salud. Universidad de Málaga. Asesor del Ministerio de Sanidad en el Comité de Cuidados de Salud.